The Solomon Center for Health Law and Policy at Yale Law School, the Yale School of Management, and the Yale School of Public Health hosted a conversation with writer Jonathan Cohn on Sept. 24.

This study characterizes the evolution of patent portfolios on all small-molecule drugs approved by the FDA from 1990 to 2019 and applied a range of measures to understand how these portfolios may be ...

The Professional Regulation and Ethics of Direct-to-Prescription Marketing - Volume 52 Issue 2

Capacity-based frameworks of personhood risk marginalizing individuals whose agency, cognition, or consciousness are diminished by illness, brain injury, or pro...

The Low Income Housing Tax Credit (LIHTC) is the largest U.S. federal affordable housing program, yet its impacts on children are largely unknown. Using geocoded Florida Natality data and LIHTC addres...

As chair of WFF, Gluck’s leadership and commitment will guide the organization to promote scholarship and create opportunities for leadership, mentoring, networking, and collaboration for women across...

This cohort study analyzes the extent to which rising health insurance premiums reflect growth in health spending vs growth in markups in the large-group market, small-group market, and in the health ...

Advocates for reform of the guardianship system are particularly pleased with the American Bar Association’s newest ethics opinion, which counsels attorneys to avoid the arrangements if at all possibl...

Why would a company offer to pay billions to see its competitors shackled alongside it? Because uniform restraints are rarely uniform in their effect.

Background Antipsychotic medications in people with dementia should be avoided or limited to treatment courses of fewer than 3–4 months. It is unknown whether discontinuation of long-term antipsychoti...

This cohort study compares underreporting of dementia diagnosis with that of other diagnosed conditions among persons with probable dementia and examines associations of underreporting with care engag...

The National Institutes of Health (NIH) has a strong interest in ensuring that the knowledge arising from research it funds is available to the scientific community and the general public. A key contr...

Download article citation: If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

BACKGROUND. Firearm injuries are the leading cause of death among US adolescents. Adolescents are among the highest risk, and those with nonfatal injuries experience high rates of reinjury. Identifying factors that predict firearm reinjury among adolescents may support tailored prevention strategies. This study sought to identify factors associated with firearm reinjury among adolescents who presented with acute nonfatal firearm injury in the St. Louis, Missouri region.METHODS. We conducted a multicenter observational cohort study of youth aged 15 to 17 years presenting to 2 adult and 2 pediatric trauma centers from 2010 through 2023. We collected data on firearm-injured patient demographics, hospital and diagnostic information, health insurance status, and mortality. Analysis included descriptive statistics, time-to-event analyses estimating reinjury probability, and adjusted hazard ratios (HRs) and 95% CIs.RESULTS. From 2010 through 2023, there were 1433 youth aged 15 to 17 years who experienced a firearm injury. Of the 1349 who survived their index injury, 233 (17.3%) experienced a reinjury during the study period. Estimated reinjury probability was 6.9% (95% CI 5.6–8.4) and 22.4% (95% CI 19.8–25.4) at 1 and 10 years, respectively. Youth who were male (HR: 4.4; 95% CI 2.1–9.3), Black (HR: 4.0; 95% CI 1.6–9.9), and treated at an adult hospital for index injury (HR: 1.5; 95% CI 1.1–2.0) had higher risk of reinjury over time.CONCLUSIONS. Black male adolescents had high risk of firearm reinjury, highlighting the critical need for interventions addressing structural racism and other root causes of community firearm violence.

As consumer digital health and wellness products become more widespread, federal regulators have issued guidance on the appropriate degree of oversight for these devices.

Annals of Surgical Oncology -

Home dialysis can offer persons with kidney failure a more individualized, flexible, and independent method of dialysis compared with in-center hemodialysis (ICHD), with similar survival outcomes. Hom...

Patient-targeted drug promotion has expanded beyond traditional advertising to the Internet, with social-media narratives shared by public figures. These new forms of marketing often evade regulato...

Four current and former fellows of the Solomon Center for Health Law and Policy at Yale Law School have been appointed to professorships at leading universities across the United States.

AbstractBackground. Understanding the prevalence of financial conflicts of interest is important in United States oncology, where cancer burden and annual

This Viewpoint discusses the potential effect of recent US Supreme Court decisions that upheld the First Amendment rights of organizations that provide substandard or even unlicensed care that deceive...

American law schools can help create the next generation of licensed legal service providers while preserving vital professional standards.

Financial abuse cost older victims nearly $2.4 billion in 2024, according to incidents reported to the Federal Trade Commission.

This secret shopper study characterizes the prescription process and clinical engagement for obtaining glucagon-like peptide-1 receptor agonists (GLP-1 RAs) from online sellers.

Opinion: After SCOTUS struck no-carry default laws, states may consider an affirmative-choice law requiring public-facing businesses to tell customers whether concealed firearms are welcome, Yale's Ia...

The attorneys who oversee the Solomon Center for Health Law and Policy at Yale Law School’s Medical-Legal Partnership (MLP) clinic discussed their work at the cutting edge of direct legal services and...

Multiple high-cost dermatologic drugs may lose patent protection and/or market exclusivity between 2027 and 2037. While the resulting introduction of generics and biosimilars has the potential to impr...

Federal policy changes are likely to make life harder for many Americans of modest means as they age.

This Viewpoint describes the role of the False Claims Act in health care fraud prevention and discusses current constitutional challenges to qui tam civil actions made possible under the act, includin...

American Journal of Public Health (AJPH) from the American Public Health Association (APHA)

ObjectiveTo examine and synthesize qualitative evidence on the experiences of older community-based caregivers of people living with dementia, guiding public...

In February, the Federal Trade Commission settled with pharmaceutical benefits manager (PBM) Express Scripts. The FTC had sued Express Scripts and two other large PBMs under the long dormant Section 5...

The Solomon Center for Health Law and Policy at Yale Law School issued a report this week on the achievements and honors of its 2025–26 student fellows.

Sixteen Yale Law School students have received the 2026 Susman Godfrey Prize, which is awarded annually to students of color who have demonstrated academic excellence and overall achievement.

This Article examines the ambitions of history-and-tradition review in and beyond the Second Amendment. In Bruen and Rahimi, the Roberts Court rejected means-end review in favor of a historical-analog...

Palliative care improves quality of life and reduces avoidable healthcare utilization for people with heart failure, yet referrals remain inconsistent…

Three expert panelists held a wide-ranging conversation on the impact of healthcare misinformation on April 14.

This Viewpoint discusses use of skinny labeling to reduce the price of brand-name drugs, impediments to timely generic market entry and affordability, and inducement liability that causes marketing un...

The Center hosted a pair of conversations with free speech, health, and technology expert Claudia Haupt.